Abtrace Funding: How Much Did They Raise & Key Investors

How Much Did Abtrace Raise?
Funding & Key Investors

Abtrace has successfully secured a major strategic investment, marking a pivotal moment in its operational trajectory. With a total funding amount reaching $2.9M, the company is well-positioned to accelerate its mission within the health technology sector. This recent funding amount of $2.9M underscores the market confidence in the firm's proprietary machine learning capabilities, which are designed to revolutionize the detection, monitoring, and treatment of chronic and long-term health conditions.

The infusion of capital serves as a catalyst for scaling Abtrace's clinical decision support tools, ensuring that healthcare providers can leverage data-driven insights to improve patient outcomes. By securing this backing, the company reinforces its commitment to integrating advanced algorithmic solutions into standard clinical workflows, effectively bridging the gap between complex medical data and actionable health interventions.

What is Abtrace?

Abtrace

Software

Healthcare Software

Business Services

Based in London, United Kingdom, Abtrace operates at the intersection of artificial intelligence and clinical medicine. The company specializes in developing sophisticated machine learning models that analyze longitudinal health data to identify early indicators of chronic disease. By automating the monitoring process, Abtrace enables clinicians to shift from reactive care models to proactive, preventative strategies. This technological approach is critical in addressing the growing burden of long-term conditions on global healthcare systems, positioning Abtrace as a key player in the digital health transformation landscape.

How much funding has Abtrace raised?

Abtrace has raised a total of $2.9M across 1 funding round:

2021

Angel/Seed

$2.9M

Angel/Seed (2021): $2.9M with participation from Ganexa Capital and Faber SpA

Key Investors in Abtrace

Ganexa Capital

Ganexa Capital is a business angel firm that invests time and money in entrepreneurial projects, particularly those with a technological focus that aim to address unmet market needs.

Faber SpA

Faber SpA is an industrial group with a global presence, known for its commitment to production technology and design excellence across multiple continents.

What's next for Abtrace?

Looking ahead, Abtrace is poised to leverage its recent capital injection to expand its footprint within the enterprise healthcare market. The strategic focus will likely center on deepening clinical integration, enhancing the scalability of its machine learning infrastructure, and pursuing regulatory milestones necessary for broader international deployment. As the company transitions from its initial development phase into a period of rapid scaling, the emphasis will remain on validating the clinical efficacy of its tools and fostering partnerships with major health systems. This growth phase is expected to solidify Abtrace's position as a leader in AI-driven chronic disease management, setting the stage for long-term sustainability and impact in the medical technology sector.

See full Abtrace company page

See More Financial Insights